{"title":"糖尿病;COVID-19的双向面","authors":"","doi":"10.36283/pjmd12-3/001","DOIUrl":null,"url":null,"abstract":"Although COVID-19 hypothetically, is to cause lethal respiratory disease, yet it led to many metabolic co-morbidities including hyperglycemia. New-onset diabetes was observed as one of the more frequent co-morbidities of COVID-19. The subjects, who had developed hyperglycemia with raised HbA1c, neither had previous diabetes nor had a family history of diabetes, with normal levels of HbA1c.","PeriodicalId":422346,"journal":{"name":"PJMD 12-3","volume":"7 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Diabetes; the bidirectional face of COVID-19\",\"authors\":\"\",\"doi\":\"10.36283/pjmd12-3/001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Although COVID-19 hypothetically, is to cause lethal respiratory disease, yet it led to many metabolic co-morbidities including hyperglycemia. New-onset diabetes was observed as one of the more frequent co-morbidities of COVID-19. The subjects, who had developed hyperglycemia with raised HbA1c, neither had previous diabetes nor had a family history of diabetes, with normal levels of HbA1c.\",\"PeriodicalId\":422346,\"journal\":{\"name\":\"PJMD 12-3\",\"volume\":\"7 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"PJMD 12-3\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36283/pjmd12-3/001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"PJMD 12-3","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36283/pjmd12-3/001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Although COVID-19 hypothetically, is to cause lethal respiratory disease, yet it led to many metabolic co-morbidities including hyperglycemia. New-onset diabetes was observed as one of the more frequent co-morbidities of COVID-19. The subjects, who had developed hyperglycemia with raised HbA1c, neither had previous diabetes nor had a family history of diabetes, with normal levels of HbA1c.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
